Urologic Oncology-Seminars and Original Investigations

Papers
(The H4-Index of Urologic Oncology-Seminars and Original Investigations is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Festschrift essay to celebrate Dr. Michael Droller54
Cover 2 - Masthead44
Genetic variations related to the prostate cancer risk: A field synopsis and revaluation by Bayesian approaches of genome-wide association studies39
PSA kinetics and predictors of PSA response in metastatic hormone-sensitive prostate cancer treated with androgen receptor signaling inhibitors39
GROWTH OF VON HIPPEL-LINDAU (VHL)-ASSOCIATED RENAL TUMORS DURING PREGNANCY36
UTILITY OF C-REACTIVE PROTEIN LEVELS IN IMPROVING RISK STRATIFICATION IN METASTATIC RENAL CELL CARCINOMA34
A QUALITATIVE EXPLORATION OF THE EXPERIENCE OF TRANSGENDER AND GENDER NONCONFORMING PATIENTS WITH GENITOURINARY AND GYNECOLOGIC MALIGNANCIES33
Extracellular vesicles in renal cell carcinoma: A review of the current landscape and future directions32
Morbidity and mortality of multivisceral resection with radical nephrectomy for locally advanced renal cell carcinoma: An analysis of the National Surgical Quality Improvement Program (NSQIP) database32
The role of enhanced recovery after surgery protocols in the development of acute kidney injury following radical cystectomy31
Salvage local treatment for recurrent prostate cancer after focal therapy: A systematic review and meta-analysis31
Postchemotherapy retroperitoneal lymph node dissection (PC-RPLND) for seminoma: Limitations of surgical intervention after first-line chemotherapy31
Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma30
Impact of the controlling nutritional status (CONUT) score on perioperative morbidity and oncological outcomes in patients with bladder cancer treated with radical cystectomy30
National trends in clinical and pathologic staging for upper tract urothelial carcinoma: Implications for neoadjuvant chemotherapy29
The effect of race/ethnicity on active treatment rates among septuagenarian or older low risk prostate cancer patients27
Radical prostatectomy for patients with high-risk, very-high risk, or radiographic suspicion for metastatic prostate cancer: Perioperative and early oncologic results from the MUSIC statewide collabor27
Methodological considerations for systematic review and meta-analysis of Xpert bladder cancer monitor26
Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer25
Is YouTube a good resource for patients to better understand kidney cancer?25
Carbonic anhydrase 10 functions as a tumor suppressor in renal cell carcinoma and its methylation is a risk factor for survival outcome25
Predictive factors associated with differential pathologic response to neoadjuvant chemohormonal therapy in high-risk localized prostate cancer24
Investigation of prognostic biomarkers in patients with urothelial carcinoma treated with platinum-based regimens24
Comparing the prognostic models to predict oncologic outcomes in patients with renal cell carcinoma: is AUC close enough to clinical practice?24
Guideline discordant care in patients with metastatic germ cell tumors24
0.063941955566406